Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
Schedule a COVID vaccine appointment:
call us 8am to 5pm, Monday through Friday, at 267-758-4902.
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Recognized by America's Top Doctors, 2007, 2008, 2010 - 2018
Recognized by Best Doctors in America 2003 - 2018
Recognized by Main Line Today's Top Doctor's 2016 issue
Recognized annually in Philadelphia magazine's Top Docs issues, 2004 - 2020
Perelman Center for Advanced Medicine
Abramson Cancer Center, West Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
Penn Medicine Valley Forge
1001 Chesterbrook Boulevard
Berwyn, PA 19312
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Taekyoung Kwak, Fang Wang, Hui Deng, Thomas Condamine, Vinit Kuma, Michela Perego, Andrew Kossenkov Luis J Montaner, Xiaowei Xu, Wei Xu, Cathy Zheng, Lynn M Schuchter, Ravi K Amaravadi, Tara C Mitchell, Giorgos C Karakousis, Charles Mulligan, Brian Nam, Gregory Masters, Neil Hockstein, Joseph Bennett, Yulia Nefedova, Dmitry I Gabrilovich: Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer Cell Rep. 33 (13): 2020.
Manz CR, Parikh RB, Small DS, Evans CN, Chivers C, Regli SH, Hanson CW, Bekelman JE, Rareshide CAL, O'Connor N, Schuchter LM, Shulman LN, Patel MS.: Effect of Integrating Machine Learning Mortality Estimates With Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients With Cancer: A Stepped-Wedge Cluster Randomized Clinical Trial.
JAMA Oncol. 6 (12): 2020.
Manz CR, Chen J, Liu M, Chivers C, Regli SH, Braun J, Draugelis M, Hanson CW, Shulman LN, Schuchter LM, O'Connor N, Bekelman JE, Patel MS, Parikh RB: Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer
JAMA Oncol. 6 (11): 1723-30,2020.
Kersh AE, Schuchter LM, Elenitsas R, Chu EY: Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy.
Immunotherapy 12 (13): 952-656,2020.
Song Y, Straker RJ 3rd, Xu X, Elder DE, Gimotty PA, Huang AC, Mitchell TC, Amaravadi RK, Schuchter LM, Karakousis GC: Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III Melanoma
Ann Surg Oncol. 27 (8): 2915-2926,2020.
Beltra JC, Manne S, Abdel-Hakeem MS, Kurachi M, Giles JR, Chen Z, Casella V, Ngiow SF, Khan O, Huang YJ, Yan P, Nzingha K, Xu W, Amaravadi RK, Xu X, Karakousis GC, Mitchell TC, Schuchter LM, Huang AC, Wherry EJ: Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
Immunity 52 (5): 825-841,2020.
Mohiuddin JJ, Chu B, Facciabene A, Poirier K, Wang X, Doucette A, Zheng C, Xu W, Anstadt EJ, Amaravadi RK, Karakousis GC, Mitchell TC, Huang AC, Shabason JE, Lin A, Swisher-McClure S, Maity A, Schuchter LM, Lukens JN: Association of antibiotic exposure with survival and toxicity in patients with melanoma receiving immunotherapy
J. Natl Cancer Inst. : 2020.
Manz CR, Parikh RB, Evans CN, Chivers C, Regli SH, Bekelman JE, Small D, Rareshide CAL, O'Connor N, Schuchter LM, Shulman LN, Patel MS: Integrating machine-generated mortality estimates and behavioral nudges to promote serious illness conversations for cancer patients: Design and methods for a stepped-wedge cluster randomized controlled trial
Contemp Clin Trials. : 2020.
Marie R. Webster, Mitchell E. Fane, Gretchen M. Alicea, Subhasree Basu, Andrew V. Kossenkov, Gloria E. Marino, Stephen M. Douglass, Amanpreet Kaur, Brett L. Ecker, Keerthana Gnanapradeepan, Abibatou Ndoye, Curtis Kugel, Alexander Valiga, Jessica Palmer, Qin Liu, Xiaowei Xu, Jessicamarie Morris, Xiangfan Yin, Hong Wu, Wei Xu, Cathy Zheng, Giorgos C. Karakousis, Ravi K. Amaravadi, Tara C. Mitchell, Filipe V. Almeida, Min Xiao, Vito W. Rebecca, Ying-Jie Wang, Lynn M. Schuchter, Meenhard Herlyn, Maureen E. Murphy, Ashani T. Weeraratna: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma Mol Cell. 77 (3): 633-644,2020.
Parikh RB, Manz C, Chivers C, Regli SH, Braun J, Draugelis ME, Schuchter LM, Shulman LN, Navathe AS, Patel MS, O'Connor NR: Machine Learning Approaches to Predict 6-Month Mortality Among Patients With Cancer
JAMA Netw Open. 2 (10): 2019.
Division of Hematology Oncology Perelman Center for Advanced Medicine10th Floor, South PavilionOffice #10-1313400 Civic Center Blvd
Patient appointments: 800-789-7366